The finding of both TIM-1+ B cells and pSTAT3+ B cells within B-cell clusters in human SCC tumours may suggest an immunosuppressive microenvironment to promote cancer progression, and could offer novel oncological, therapeutic targets. This evidence concerns the gene HAVCR1 and cancer.